 Ryan Peterson
Concepts (98)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cellulitis | 1 | 2017 | 46 | 0.580 |
Why?
| | Hot Temperature | 1 | 2017 | 303 | 0.520 |
Why?
| | Hypertension, Pulmonary | 1 | 2022 | 1749 | 0.380 |
Why?
| | Seasons | 3 | 2017 | 449 | 0.370 |
Why?
| | Surgical Wound Infection | 2 | 2017 | 250 | 0.240 |
Why?
| | Arthritis, Rheumatoid | 2 | 2023 | 1002 | 0.240 |
Why?
| | Patient Acuity | 1 | 2024 | 42 | 0.230 |
Why?
| | Teaching Rounds | 1 | 2024 | 64 | 0.210 |
Why?
| | Workload | 1 | 2024 | 133 | 0.210 |
Why?
| | Pulmonary Atelectasis | 1 | 2022 | 12 | 0.200 |
Why?
| | Glycocalyx | 1 | 2022 | 21 | 0.200 |
Why?
| | Matrix Metalloproteinase 7 | 1 | 2021 | 24 | 0.200 |
Why?
| | Glycosaminoglycans | 1 | 2022 | 80 | 0.190 |
Why?
| | Rheumatoid Factor | 1 | 2022 | 157 | 0.190 |
Why?
| | Hospitalization | 2 | 2022 | 1765 | 0.190 |
Why?
| | Scleroderma, Systemic | 1 | 2021 | 95 | 0.190 |
Why?
| | Models, Statistical | 2 | 2022 | 606 | 0.180 |
Why?
| | Automobile Driving | 1 | 2022 | 129 | 0.180 |
Why?
| | Intensive Care Units | 1 | 2024 | 622 | 0.170 |
Why?
| | Lung Diseases, Interstitial | 2 | 2022 | 520 | 0.170 |
Why?
| | Respiratory Insufficiency | 1 | 2023 | 292 | 0.160 |
Why?
| | Autoantibodies | 2 | 2023 | 1360 | 0.160 |
Why?
| | Self Efficacy | 1 | 2022 | 361 | 0.160 |
Why?
| | Cognitive Dysfunction | 1 | 2023 | 279 | 0.160 |
Why?
| | Decision Support Techniques | 1 | 2022 | 353 | 0.160 |
Why?
| | Weather | 1 | 2017 | 25 | 0.150 |
Why?
| | Firearms | 1 | 2022 | 292 | 0.140 |
Why?
| | Cognition | 1 | 2024 | 980 | 0.140 |
Why?
| | Suicide | 1 | 2022 | 501 | 0.140 |
Why?
| | Acute Kidney Injury | 1 | 2023 | 646 | 0.130 |
Why?
| | Arthroplasty, Replacement, Hip | 1 | 2017 | 109 | 0.130 |
Why?
| | Patient Admission | 1 | 2017 | 175 | 0.130 |
Why?
| | Colorado | 2 | 2022 | 4113 | 0.130 |
Why?
| | Coronary Artery Disease | 1 | 2020 | 607 | 0.120 |
Why?
| | Registries | 1 | 2022 | 1770 | 0.120 |
Why?
| | Temperature | 1 | 2017 | 587 | 0.120 |
Why?
| | Arthroplasty, Replacement, Knee | 1 | 2017 | 246 | 0.110 |
Why?
| | Humans | 16 | 2024 | 115589 | 0.110 |
Why?
| | Liver Transplantation | 1 | 2020 | 830 | 0.110 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2018 | 1216 | 0.110 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2018 | 538 | 0.100 |
Why?
| | Incidence | 1 | 2017 | 2335 | 0.090 |
Why?
| | Epitopes | 2 | 2023 | 438 | 0.090 |
Why?
| | Risk Factors | 3 | 2020 | 8697 | 0.090 |
Why?
| | Prognosis | 3 | 2022 | 3339 | 0.080 |
Why?
| | Female | 8 | 2024 | 59913 | 0.080 |
Why?
| | United States | 5 | 2022 | 12295 | 0.070 |
Why?
| | Male | 7 | 2024 | 55949 | 0.070 |
Why?
| | Proportional Hazards Models | 2 | 2020 | 1087 | 0.070 |
Why?
| | Predictive Value of Tests | 2 | 2022 | 1805 | 0.070 |
Why?
| | Decision Making | 2 | 2023 | 791 | 0.070 |
Why?
| | Aged | 5 | 2023 | 19250 | 0.060 |
Why?
| | Retrospective Studies | 4 | 2023 | 12608 | 0.060 |
Why?
| | Middle Aged | 3 | 2017 | 26998 | 0.050 |
Why?
| | Immunoglobulin Isotypes | 1 | 2022 | 32 | 0.050 |
Why?
| | Washington | 1 | 2022 | 134 | 0.050 |
Why?
| | Transportation | 1 | 2022 | 44 | 0.050 |
Why?
| | Independent Living | 1 | 2023 | 84 | 0.050 |
Why?
| | Social Isolation | 1 | 2022 | 54 | 0.050 |
Why?
| | Ownership | 1 | 2022 | 81 | 0.050 |
Why?
| | Immunoglobulin A | 1 | 2022 | 173 | 0.050 |
Why?
| | Alveolar Epithelial Cells | 1 | 2022 | 100 | 0.050 |
Why?
| | Immunoglobulin M | 1 | 2022 | 254 | 0.050 |
Why?
| | Prospective Studies | 2 | 2022 | 6264 | 0.050 |
Why?
| | Educational Status | 1 | 2023 | 413 | 0.050 |
Why?
| | Staurosporine | 1 | 2018 | 21 | 0.040 |
Why?
| | Hospital Mortality | 1 | 2023 | 779 | 0.040 |
Why?
| | Coronary Angiography | 1 | 2020 | 307 | 0.040 |
Why?
| | Respiration, Artificial | 1 | 2022 | 526 | 0.040 |
Why?
| | Remission Induction | 1 | 2018 | 240 | 0.040 |
Why?
| | Critical Illness | 1 | 2023 | 645 | 0.040 |
Why?
| | Statistics, Nonparametric | 1 | 2018 | 390 | 0.040 |
Why?
| | Disease-Free Survival | 1 | 2018 | 621 | 0.030 |
Why?
| | Sex Factors | 1 | 2022 | 1736 | 0.030 |
Why?
| | Aged, 80 and over | 2 | 2017 | 6417 | 0.030 |
Why?
| | Delivery of Health Care | 1 | 2023 | 844 | 0.030 |
Why?
| | Survival Analysis | 1 | 2018 | 1219 | 0.030 |
Why?
| | Odds Ratio | 1 | 2017 | 962 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2022 | 2800 | 0.030 |
Why?
| | Health Care Costs | 1 | 2017 | 384 | 0.030 |
Why?
| | Pandemics | 1 | 2022 | 1334 | 0.030 |
Why?
| | Medicaid | 1 | 2017 | 411 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2023 | 4435 | 0.030 |
Why?
| | Models, Theoretical | 1 | 2017 | 519 | 0.030 |
Why?
| | Hospitals | 1 | 2017 | 585 | 0.030 |
Why?
| | Comorbidity | 1 | 2017 | 1473 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2020 | 2578 | 0.030 |
Why?
| | Databases, Factual | 1 | 2017 | 1138 | 0.030 |
Why?
| | Medicare | 1 | 2017 | 666 | 0.030 |
Why?
| | Patient Readmission | 1 | 2017 | 609 | 0.030 |
Why?
| | Young Adult | 2 | 2017 | 10470 | 0.030 |
Why?
| | Patient Discharge | 1 | 2017 | 770 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2022 | 4665 | 0.020 |
Why?
| | Adolescent | 2 | 2017 | 17890 | 0.020 |
Why?
| | Antineoplastic Agents | 1 | 2018 | 1893 | 0.020 |
Why?
| | Adult | 2 | 2017 | 30719 | 0.020 |
Why?
| | Mice | 1 | 2022 | 15052 | 0.020 |
Why?
| | Animals | 1 | 2022 | 32102 | 0.010 |
Why?
|
|
Peterson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|